Saturday, 2 August 2025
  
Login

Australia's most trusted
source of pharma news

Saturday, 02 August 2025
News

Cash bonanza for Aussie start-ups

Posted 29 July 2025 PM

Brandon Capital has raised $439 million for Brandon BioCatalyst Fund Six, almost $100 million more than it envisioned, with government joining in.

The fund launched a little over a year ago with hopes of raising up to $350 million to invest in emerging biomedical technologies with strong commercial potential, with the aim of translating the discoveries into high-growth firms that positively impact human health.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (17)

Clinical & Medical, R&D (6)

Regulatory, Pharmacovigilance & QA (6)

Devices (1)

Other (13)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.